CD Biosynsis provides a comprehensive nanotechnology toolbox and fully integrated platforms to power synthetic biology research. We can provide our customers with tailored solutions that meet specific research objectives and diverse applications to help them solve any problems encountered in their projects and bring breakthrough ideas to fruition.
Synthetic biology relies on tools from genetic engineering, systems biology, computer science, and many other disciplines to achieve the goal of designing and creating biological components and systems that do not already exist in nature, as well as redesigning existing biological molecules, structures, and organisms. It has the potential to be one of the most powerful emerging technologies today. Synthetic biology and nanotechnology were initially developed independently. With advances in technology, synthetic biology and nanotechnology have emerged together as complementary sciences and technologies, dedicated to the engineering of functional assemblies. Today, synthetic biology could provide the tools and understanding needed to develop nanotechnology more systematically.
The convergence between synthetic biology and nanotechnology can be inferred from the fact that they jointly exploit the spatial organization from nano- to micrometer scale. Predictable nucleic acid interactions have been used by nucleic acid nanotechnology to implement programmable molecular systems, making it possible to produce complex nanostructures and construct artificial systems from biological molecules such as DNA and RNA by self-assembly. This is compatible with the recent development of synthetic biology. The joint development of synthetic biology and nanotechnology will provide powerful tools for the generation of synthetic supramolecular systems with well-defined and useful biological functions for industrial applications in the future. Continued advances in these two fields and the narrowing of the complexity gap between in vitro and in vivo systems have enabled a variety of potential applications of synthetic bionanotechnology, ranging from intracellular circuits for the detection and treatment of disease to synthetic enzymatic pathways for the efficient production of novel drug molecules.
Figure 1. Synthetic RNA nanostructures. (Kim J & Franco E, 2020)
CD Biosynsis offers integrated nanotechnology platforms to help customers overcome the challenges of synthetic biology projects and accelerate their journey to success.
CD Biosynsis is committed to the establishment of advanced technology platforms and is adept at tailoring services and solutions to the customer's needs and circumstances. We are confident in the validity and reproducibility of the results we deliver because all of our services and products are based on reliable technologies and optimized protocols to meet high standards.
To start your synthetic biology projects, please feel free to contact us for more details. Our experienced scientists are available for on-demand customer assistance to help you with any concerns you may have.